99 related articles for article (PubMed ID: 26081173)
1. Uptake of health monitoring and disease self-management in Australian adults with neurofibromatosis type 1: strategies to improve care.
Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
Clin Genet; 2016 Mar; 89(3):385-91. PubMed ID: 26081173
[TBL] [Abstract][Full Text] [Related]
2. The Impact of Neurofibromatosis Type 1 on the Health and Wellbeing of Australian Adults.
Crawford HA; Barton B; Wilson MJ; Berman Y; McKelvey-Martin VJ; Morrison PJ; North KN
J Genet Couns; 2015 Dec; 24(6):931-44. PubMed ID: 25894096
[TBL] [Abstract][Full Text] [Related]
3. Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge.
Oates EC; Payne JM; Foster SL; Clarke NF; North KN
Am J Med Genet A; 2013 Apr; 161A(4):659-66. PubMed ID: 23427176
[TBL] [Abstract][Full Text] [Related]
4. Characterization of health concerns in people with neurofibromatosis type 1.
Fleming J; Morgan O; Wong C; Schlub TE; Berman Y
Mol Genet Genomic Med; 2023 Jan; 11(1):e2077. PubMed ID: 36444392
[TBL] [Abstract][Full Text] [Related]
5. Quality of Life in Adults with Neurofibromatosis 1 in Brazil.
Bicudo NP; de Menezes Neto BF; da Silva de Avó LR; Germano CM; Melo DG
J Genet Couns; 2016 Oct; 25(5):1063-74. PubMed ID: 26944915
[TBL] [Abstract][Full Text] [Related]
6. [Neurofibromatosis type 1 in children. Experiences of the Gdansk Paediatric Oncohaematology Centre. Preliminary results].
Sierota D; Stefanowicz J; Wierzba J; Adamkiewicz-Drozyńska E; Wybieralska-Dubaniewicz M; Kosiak W; Komasara L; Czauderna P; Izycka-Swieszewska E; Pilarska E; Birkholtz D; Stachowicz-Stencel T; Połczyńska K; Bień E; Szołkiewicz A; Stefanowicz A; Balcerska A
Med Wieku Rozwoj; 2007; 11(3 Pt 2):307-12. PubMed ID: 18663272
[TBL] [Abstract][Full Text] [Related]
7. Worries and needs of adults and parents of adults with neurofibromatosis type 1.
Rietman AB; van Helden H; Both PH; Taal W; Legerstee JS; van Staa A; Moll HA; Oostenbrink R; van Eeghen AM
Am J Med Genet A; 2018 May; 176(5):1150-1160. PubMed ID: 29681082
[TBL] [Abstract][Full Text] [Related]
8. [Care recommendations for type 1 neurofibromatosis].
Donadio A; Garavelli L; Lorenzetti ME; Villani AR; Banchini G; Virdis R
Acta Biomed Ateneo Parmense; 2000; 71(3-4):83-7. PubMed ID: 11424620
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.
Mansouri A; Ghadakzadeh S; Maqbool T; Barnett C; Au K; Kongkham P; Bril V; Gelareh Z
Can J Neurol Sci; 2017 Sep; 44(5):577-588. PubMed ID: 27821212
[TBL] [Abstract][Full Text] [Related]
10. [Advances in diagnosis and treatment of neurofibromatosis type 1].
Zheng JW; Sun J; Zhang ZY
Shanghai Kou Qiang Yi Xue; 2007 Dec; 16(6):561-9. PubMed ID: 18278402
[TBL] [Abstract][Full Text] [Related]
11. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
12. Guidelines for the diagnosis and management of individuals with neurofibromatosis 1.
Ferner RE; Huson SM; Thomas N; Moss C; Willshaw H; Evans DG; Upadhyaya M; Towers R; Gleeson M; Steiger C; Kirby A
J Med Genet; 2007 Feb; 44(2):81-8. PubMed ID: 17105749
[TBL] [Abstract][Full Text] [Related]
13. Health Survey of Adults with Neurofibromatosis 1 Compared to Population Study Controls.
Fjermestad KW; Nyhus L; Kanavin ØJ; Heiberg A; Hoxmark LB
J Genet Couns; 2018 Sep; 27(5):1102-1110. PubMed ID: 29429039
[TBL] [Abstract][Full Text] [Related]
14. Young adults' experience of living with neurofibromatosis type 1.
Hummelvoll G; Antonsen KM
J Genet Couns; 2013 Apr; 22(2):188-99. PubMed ID: 22815101
[TBL] [Abstract][Full Text] [Related]
15. [Quality of life in children with neurofibromatosis type 1, based on their mothers' reports].
Saltık S; Başgül ŞS
Turk Psikiyatri Derg; 2013; 24(1):25-34. PubMed ID: 23446537
[TBL] [Abstract][Full Text] [Related]
16. In Vivo Detection of Choroidal Abnormalities Related to NF1: Feasibility and Comparison With Standard NIH Diagnostic Criteria in Pediatric Patients.
Parrozzani R; Clementi M; Frizziero L; Miglionico G; Perrini P; Cavarzeran F; Kotsafti O; Comacchio F; Trevisson E; Convento E; Fusetti S; Midena E
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):6036-42. PubMed ID: 26393470
[TBL] [Abstract][Full Text] [Related]
17. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
[TBL] [Abstract][Full Text] [Related]
18. Differences of 25-hydroxyvitamin D3 concentrations in children and adults with neurofibromatosis type 1.
Schnabel C; Dahm S; Streichert T; Thierfelder W; Kluwe L; Mautner VF
Clin Biochem; 2014 May; 47(7-8):560-3. PubMed ID: 24613576
[TBL] [Abstract][Full Text] [Related]
19. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
20. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
Pinson S; Wolkenstein P
Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
